Filtered By:
Condition: Dermatitis
Countries: Italy Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Conclusions: Dupilumab significantly improved disease severity, pruritus, sleep loss and quality of life with an acceptable safety profile.
PMID: 31647347 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - October 27, 2019 Category: Dermatology Tags: J Dermatolog Treat Source Type: research
